1.Analysis on Drug Resistance and Pathogenic Bacteria Distribution of the Patients of Infectious Mononucleosis Combined with Bacterial Infec-tion
Journal of Zhejiang Chinese Medical University 2014;(2):173-174,180
[Objective] To discuss the pathogenic bacteria distribution and drug resistance of patients of infectious mononucleosis combined with bacterial in-fection. [Method] Choose 38 children patients as research objects who were diagnosed as infectious mononucleosis with positive throat swab culture, and make investigation to the separated pathogenic bacteria distribution and drug resistance.[Result] In the 38 cases of samples, there ’re 44 strains of pathogenic bacteria detected(2 kinds of pathogenic bacteria detected in 6 cases respectively), the front 3 were: 14 strains of staphylococcus aureus(31.8%), 10 acineto-bacter baumannii(22.7%) and 8 klebsiel a pneumaniae(18.2%); the staphylococcus aureus had highest drug resistance to Penicilin G, occupying 85.7%; to ampicil in, cefoxitin and macrodantin, the acinetobacter baumannii had drug resistance 100%; the klebsiel a pneumaniae had drug resistance of 100% to ampicil in.[Conclusion] The pathogenic bacteria distribution and drug resistance of children patients with infectious mononucleosis combined with bacteria infection have definite features, which shal be emphasized in diagnosis and treatment.
2.A new eudesmane sesquiterpene lactone from Curcuma wenyujin
Shisheng WANG ; Jinmei ZHANG ; Xiuhan GUO ; Qiling SONG ; Weijie ZHAO
Acta Pharmaceutica Sinica 2007;42(10):1062-1065
The aim of the study was to investigate the sesquiterpene constituents from the rhizomes of Curcuma wenyujin Y.H.Chen et C.Ling.The isolation and purification of the constituents from the 50% EtOH extracts of the rhizomes were performed with repeated column chromatography over sillica gel and macroporous resin.Eight sesquiterpenes were obtained and identified as wenyujinlactone A(1),neolitamone A(2),zedoarondiol(3),isozedoarondiol(4),aerugidiol(5),curcumol (6),curdione(7) and (1R,10R)-epoxy-(-)-1,10-dihydrocurdine (8) by means of spectral analysis.Among them,compound 1 was found to be a new eudesmane sesquiterpene lactone,whilst compounds 2-5 were obtained from this plant for the first time.
3.The effects of intestinal nematode infection on experimental periodontitis in mice
Min XIE ; Shiguang HUANG ; Qiling HUANG ; Ning SONG ; Zengfang ZHANG ; Guozhen DENG
Journal of Practical Stomatology 2009;25(6):787-790
Objective: To investigate the effect of polarizing the immune response toward the Th2 type, using intestinal nematode (Trichinella spiralis) infection, on subsequent experimental periodontitis. Methods:Thirty six SPF KM mice were randomly divided into three groups. Periodontitis group: experimental periodontitis was induced by wrapping a 5/0 silk ligature inoculated with putative periodontopathic bacteria around the first maxillary molar. Th2-polaried group: After the mice were infected with low dosage Trichinella spiralis, the experimental periodontitis model was established at that time as above. Mice were sacrificed at the end of 1, 4, 8, 12 weeks. The histological analysis of periodontal tissues was observed by microscope after the samples were stained with hematoxylin and eosin (H&E). The concentrations of IFN--y and IL-4 in mouse serum were determined by ELISA. Results; The results showed that compared with control group Th2-polaried mice had high levels of IL-4 prior nematode infection reduced the severity of periodontitis, and subsequent infection of the periodontium with oral pathogens developed minimal lesions. Few or no osteoclasts were detected in lesions of Th2-polaried group. Conclusion;These results indicate a protective role of nematode infection in Thl cell-driven periodontal damage and prompt consideration of a novel therapeutic strategy in periodontitis based on im-munological distraction.
4.Optimal Ratio of Rehmanniae Radix and Lilii Bulbus in Baihe Dihuangtang Based on Antidepressant Activity and Its Mechanism
Mingzhu GONG ; Yueyue ZHANG ; Lingling SONG ; Yiting WANG ; Junming WANG ; Yanmei WANG ; Xiaohui WU ; Qiling YANG
Chinese Journal of Experimental Traditional Medical Formulae 2022;28(21):58-65
ObjectiveBased on the antidepressant activity, the optimal ratio of Rehmanniae Radix and Lilii Bulbus in Baihe Dihuangtang was optimized and its possible mechanism was preliminarily explored. MethodA total of 100 male mice were randomly divided into normal group, model group, Rehmanniae Radix single decoction group, Lilii Bulbus single decoction group, and 5 different ratios of Baihe Dihuangtang group (Rehmanniae Radix-Lilii Bulbus 5∶6, 5∶5 , 5∶4, 5∶3, 5∶2), fluoxetine hydrochloride group. Except for the normal group, the remaining 9 groups were treated with chronic unpredictable mild stress method (CUMS) for 21 consecutive days to establish the depression mouse model.The Rehmanniae Radix single decoction group, Lilii Bulbus single decoction group and 5 different ratios of Baihe Dihuangtang group were administered with corresponding drugs at a dose of 2 g·kg-1 respectively, and fluoxetine hydrochloride group was administered fluoxetine hydrochloride at a dose of 0.01 g·kg-1, the normal group and the model group were respectively given an equal volume of normal saline by gavage for 21 consecutive days. The antidepressant effect of Baihe Dihuangtang with different ratios was evaluated by behavioral experiments. Western blot was used to detect the expression levels of brain-derived neurotrophic factor (BDNF) and tyrosine kinase receptor B (TrkB) in hippocampus. The level of total superoxide dismutase (SOD) in hippocampus was detected by hydroxylamine method. The level of reduced glutathione (GSH) in hippocampus was detected by spectrophotometric method. The levels of glutathione peroxidase (GPX) and glutathione S-transferase (GST) in hippocampus was detected by colorimetric method. The level of malondialdehyde (MDA) in hippocampus was detected by thiobarbituric acid method, and preliminary exploration of its antidepressant mechanism. ResultCUMS caused a significant decrease in the preference rate of sugar water and a significant prolongation of forced swimming and tail suspension immobility time (P<0.01), while the different ratios of Baihe Dihuangtang and the single decoction of Rehmanniae Radix and Lilii Bulbus were significantly reversed to varying degrees. Abnormalities of the above indicators were observed (P<0.05, P<0.01), especially when the ratio of 5∶6 had the most obvious effect on the above indicators, Moreover, CUMS caused the hippocampal BDNF and the expression of TrkB, SOD and glutathione antioxidant-related indexes were significantly decreased (P<0.01), and the levels of lipid peroxidation product MDA was significantly increased (P<0.01). However, the superior ratio of Baihe Dihuangtang (Rehmanniae Radix-Lilii Bulbus 5∶6, 5∶5, 5∶4) and the single decoction of Rehmanniae Radix and Lilii Bulbus significantly reversed the abnormality of the above indicators to varying degrees (P<0.05, P<0.01). ConclusionIn summary, 5 different ratios of Baihe Dihuangtang and the single decoction of Rehmanniae Radix and Lilii Bulbus can produce antidepressant effect, especially when the ratio of 5∶6 had the most obvious effect on the above indicators, and the antidepressant effect gradually weakens with the proportion of Lilii Bulbus in the recipe decreases, and its mechanism may involve enhancing the nutritional level and antioxidant defense ability of hippocampal central nervous system.
5.Transplant outcomes of 100 cases of living-donor ABO-incompatible kidney transplantation.
Saifu YIN ; Qiling TAN ; Youmin YANG ; Fan ZHANG ; Turun SONG ; Yu FAN ; Zhongli HUANG ; Tao LIN ; Xianding WANG
Chinese Medical Journal 2022;135(19):2303-2310
BACKGROUND:
Although ABO-incompatible (ABOi) kidney transplantation (KT) has been performed successfully, a standard preconditioning regimen has not been established. Based on the initial antidonor ABO antibody titers, an individualized preconditioning regimen is developed, and this study explored the efficacy and safety of the regimen.
METHODS:
From September 1, 2014, to September 1, 2020, we performed 1668 consecutive living-donor KTs, including 100 ABOi and 1568 ABO-compatible (ABOc) KTs. ABOi KT recipients (KTRs) with a lower antibody titer (≤1:8) were administered oral immunosuppressive drugs (OIs) before KT, while patients with a medium titer (1:16) received OIs plus antibody-removal therapy (plasma exchange/double-filtration plasmapheresis), patients with a higher titer (≥1:32) were in addition received rituximab (Rit). Competing risk analyses were conducted to estimate the cumulative incidence of infection, acute rejection (AR), graft loss, and patient death.
RESULTS:
After propensity score analyses, 100 ABOi KTRs and 200 matched ABOc KTRs were selected. There were no significant differences in graft and patient survival between the ABOi and ABOc groups (P = 0.787, P = 0.386, respectively). After using the individualized preconditioning regimen, ABOi KTRs showed a similar cumulative incidence of AR (10.0% υs . 10.5%, P = 0.346). Among the ABOi KTRs, the Rit-free group had a similar cumulative incidence of AR ( P = 0.714) compared to that of the Rit-treated group. Multivariate competing risk analyses revealed that a Rit-free regimen reduced the risk of infection (HR: 0.31; 95% CI: 0.12-0.78, P = 0.013). Notably, antibody titer rebound was more common in ABOi KTRs receiving a Rit-free preconditioning regimen ( P = 0.013) than those receiving Rit. ABOi KTRs with antibody titer rebound had a 2.72-fold risk of AR (HR: 2.72, 95% CI: 1.01-7.31, P = 0.048). ABOi KTRs had similar serum creatinine and estimated glomerular filtration rate compared to those of ABOc KTRs after the first year.
CONCLUSIONS
An individualized preconditioning regimen can achieve comparable graft and patient survival rates in ABOi KT with ABOc KT. Rit-free preconditioning effectively prevented AR without increasing the risk of infectious events in those with lower initial titers; however, antibody titer rebound should be monitored.
Humans
;
Kidney Transplantation/adverse effects*
;
Living Donors
;
Kidney
;
Immunosuppressive Agents/therapeutic use*
;
Rituximab/therapeutic use*
;
ABO Blood-Group System
;
Graft Rejection
;
Graft Survival